| | | | |
| | RegenMD | | |
| | | | |
| | | | |
| | | This recognition is a consequence of our strong track record of growth and profitability of our core life science research tools business, even during the Great Recession, our exciting growth opportunity in regenerative medicine and the exceptional ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | Unlike other materials used in tissue engineering, the carbon nanotube patch would not naturally degrade in the body. "The idea would be that the heart tissue would grow around these carbon nanotubes and they would continue to provide electrical ... See all stories on this topic » | MIT Technology Review | | | | | | |
| |
| | | | |
| | | | |
| | | To that end, Kenneth S. Zaret, PhD, professor of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, and associate director of the Penn Institute for Regenerative Medicine, and Cheng-Ran Xu, PhD, ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | In the promising field of regenerative medicine, human perinatal stem cells are of great interest as potential stem cells with clinical applications. Perinatal stem cells could be isolated from normally discarded human placentae, which are an ideal ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | The California Institute for Regenerative Medicine is coming to town Saturday. The stem cell institute will host a free, five-hour program from 9 am to 2 pm Saturday at the Hilton Stockton. The event is titled "Inflammation: The Root of All Evil? ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | Shire's ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. The UK specialty pharma company has long eyed a move into this area and said the deal with Advanced ... See all stories on this topic » | InPharm | | | | | | |
| |
| | | | |
| | | | |
| | | | |
| |
| | | | |
| | | | |
| | | Brian P. Bilbray (R-CA) and Diana DeGette (D-CO), is called the Regenerative Medicine Promotion Act of 2011, and seeks to establish funding priorities for research and development of regenerative medicine products, and to develop a regulatory ... See all stories on this topic » | | | | | |
| |
| | | | |
No comments:
Post a Comment